Study: NCT00325130

Adverse event: Injection Site Pain quadrivalent HPV Vaccine postvaccination 1
Serious: no
Organ System: General disorders
Frequency: 315 affected / 514 at risk

Adverse event: Injection Site Swelling HPV Vaccine postvaccination 1
Serious: no
Organ System: General disorders
Frequency: 56 affected / 514 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (postvaccination 2)
Serious: no
Organ System: General disorders
Notes: qHPV = quadrivalent HPV Vaccine
Frequency: 53 affected / 506 at risk

Adverse event: Injection Site Pain qHPV Vaccine (postvaccination 2)
Serious: no
Organ System: General disorders
Frequency: 210 affected / 506 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 68 affected / 503 at risk

Adverse event: Injection Site Pain qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 253 affected / 503 at risk

Adverse event: Injection Site Swelling qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 52 affected / 503 at risk

Adverse event: Injection Site Erythema ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 121 affected / 514 at risk

Adverse event: Injection Site Pain ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 421 affected / 514 at risk

Adverse event: Injection Site Swelling ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 145 affected / 514 at risk

Adverse event: Headache Systemic Clinical
Serious: no
Organ System: Nervous system disorders
Frequency: 113 affected / 520 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (post-vaccination 1)
Serious: no
Organ System: General disorders
Frequency: 37 affected / 514 at risk

Adverse event: Injection Site Swelling qHPV Vaccine (post-vaccination 2)
Serious: no
Organ System: General disorders
Frequency: 42 affected / 506 at risk

Adverse event: Injection Site Bruising ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 30 affected / 514 at risk

Adverse event: Abdominal pain upper
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 27 affected / 520 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 45 affected / 520 at risk

Adverse event: Laryngeal pain
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 26 affected / 520 at risk

Adverse event: Muscular weakness
Serious: yes
Organ System: Musculoskeletal and connective tissue disorders
Frequency: 1 affected / 498 at risk

Adverse event: Parotidectomy
Serious: yes
Organ System: General disorders
Frequency: 1 affected / 498 at risk

Adverse event: Injection Site Pain quadrivalent HPV Vaccine postvaccination 1
Serious: no
Organ System: General disorders
Frequency: 228 affected / 406 at risk

Adverse event: Injection Site Swelling HPV Vaccine postvaccination 1
Serious: no
Organ System: General disorders
Frequency: 28 affected / 406 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (postvaccination 2)
Serious: no
Organ System: General disorders
Notes: qHPV = quadrivalent HPV Vaccine
Frequency: 61 affected / 492 at risk

Adverse event: Injection Site Pain qHPV Vaccine (postvaccination 2)
Serious: no
Organ System: General disorders
Frequency: 194 affected / 492 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 60 affected / 485 at risk

Adverse event: Injection Site Pain qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 234 affected / 485 at risk

Adverse event: Injection Site Swelling qHPV Vaccine (postvaccination 3)
Serious: no
Organ System: General disorders
Frequency: 55 affected / 485 at risk

Adverse event: Injection Site Erythema ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 107 affected / 401 at risk

Adverse event: Injection Site Pain ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 303 affected / 401 at risk

Adverse event: Injection Site Swelling ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 113 affected / 401 at risk

Adverse event: Headache Systemic Clinical
Serious: no
Organ System: Nervous system disorders
Frequency: 114 affected / 498 at risk

Adverse event: Injection Site Erythema qHPV Vaccine (post-vaccination 1)
Serious: no
Organ System: General disorders
Frequency: 26 affected / 406 at risk

Adverse event: Injection Site Swelling qHPV Vaccine (post-vaccination 2)
Serious: no
Organ System: General disorders
Frequency: 48 affected / 492 at risk

Adverse event: Injection Site Bruising ADACEL™ + Menactra™
Serious: no
Organ System: General disorders
Frequency: 9 affected / 401 at risk

Adverse event: Abdominal pain upper
Serious: no
Organ System: Gastrointestinal disorders
Frequency: 26 affected / 498 at risk

Adverse event: Pyrexia
Serious: no
Organ System: General disorders
Frequency: 50 affected / 498 at risk

Adverse event: Laryngeal pain
Serious: no
Organ System: Respiratory, thoracic and mediastinal disorders
Frequency: 35 affected / 498 at risk